Aktuellt

Featured Image
SUMMARY Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025....
3 april 2026
 · 
2 min read
Featured Image
This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS...
3 april 2026
 · 
3 min read
Featured Image
In modern care, patients are expected to be empowered and to actively participate in decision making regarding their own healthcare. And on...
3 april 2026
 · 
3 min read
Featured Image
A preview of new insights into COPD and comorbidities Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive...
1 april 2026
 · 
8 min read
Featured Image
SUMMARY Why we still need to address inhalation technique. Effective inhaler therapy hinges on matching the right device to the right patient—and...
31 mars 2026
 · 
5 min read
Featured Image
SUMMARY Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma?...
31 mars 2026
 · 
3 min read
Featured Image
SUMMARY Some get off to a bad start, others simply do not realize they have a disease. And others fall into the...
31 mars 2026
 · 
4 min read
Featured Image
SUMMARY Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and...
31 mars 2026
 · 
6 min read
Featured Image
SUMMARY Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and...
31 mars 2026
 · 
4 min read
Featured Image
Clinical remission in adults with moderate-to-severe asthma A new framework from Professor Celeste Porsbjerg’s team redefines remission in severe asthma by focusing...
31 mars 2026
 · 
2 min read
Featured Image
SUMMARY Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma, with estrogen...
31 mars 2026
 · 
4 min read
Chiesi Logo – 1. website_Primary_pant_RGB

Chiesi er et familieeid legemiddelselskap grunnlagt i 1935. Vi tror på innovasjon, ansvar og menneskelig empati. Vår lidenskap er å forbedre livskvaliteten for pasienter over hele verden gjennom forskning, utvikling og bærekraftige løsninger. 

© 2026 Chiesi Pharma AB. Dette nettstedet er beregnet på helsepersonell i Norge.